Biotechs

Pharma firm Bharat Biotech on Monday announced that its intranasal covid-19 vaccine iNCOVACC (BBV154) has received approval from the Central Drugs Standard Control Organization (CDSCO) for…

The Drugs Controller General of India has given restricted emergency use authorisation to BharatBiotech's Covaxin for children between the age of 6-12 years, according to sources. This development comes following recommendations by the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation(CDSCO). The SEC had last week reviewed the application of both the companies seeking emergency use authorisation for Corbevax and Covaxin for use…